Cargando...
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance
The unmatched efficacy of microtubule-targeting agents (MTAs) as chemotherapeutics was once assumed to originate from their impact on mitotic processes; however, this misconception is being eroded by amassing data that MTAs instead target interphase functions in patients’ tumors. What remains murky...
Gardado en:
| Publicado en: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457617/ https://ncbi.nlm.nih.gov/pubmed/25695344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.1016425 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|